Vestis Corporation delivered its Q3 results on August 11 into a market that was already edging more cautious — and the options and short interest data both moved sharply in the same direction within hours of the print.
The clearest post-earnings signal is in options. Defensive positioning jumped to its most elevated level in months, with the put/call ratio hitting 1.47 on August 11 — more than two standard deviations above its 20-day average of 1.18. That's the most bearish options lean since early July, when the PCR ran above 1.80. The spike is a clean break from the prior week's relatively balanced reading of around 1.01, suggesting options traders used the earnings day to load up on downside protection. Short interest reinforced that tone: estimated shares short rose roughly 9.7% on the day to 5.56% of the free float, the highest level in about two weeks and a notable reversal after a month of steady covering. That said, the borrow market itself is not the constraint here — availability is extremely loose at over 1,100%, meaning shares to borrow are plentiful and cost to borrow has actually eased, running at 0.47% after a 17% decline on the week. Shorts are rebuilding, but not because they're scrambling for borrow; the lending market offers no friction whatsoever.
The Street response to earnings was a round of target upgrades with no rating changes — a cautious endorsement rather than a conviction shift. Goldman Sachs raised its target from $8.20 to $9.30 today while holding its Sell rating, still more than 30% below the current $13.88 price. Stifel lifted to $14.00 from $11.00 but stayed at Hold. Baird went to $16.00 from $15.00, also keeping Neutral. The mean consensus target across the coverage group sits near $12.00 — below where the stock is trading now — which frames the analyst community as broadly skeptical of the current price level despite the constructive target revisions. The stock has more than doubled year-to-date, and the PE multiple has compressed to around 20.7x as earnings expectations have caught up; EV/EBITDA near 9.8x has drifted modestly lower over the past month. Factor scores paint a mixed picture: the short score ranks in just the 26th percentile of peers, days-to-cover in the 19th, suggesting the market's short-side pressure is not yet extreme by historical standards — but both ticked higher this week.
The ownership structure adds an important layer. Corvex Management, the activist hedge fund run by Keith Meister, holds close to 15% of shares outstanding and last bought aggressively in December 2025 when the stock was trading near $6.80. Corvex added no new shares in the most recent reporting period, but its concentrated position means any sign of operational progress — or deterioration — at Vestis has outsized implications for the register. BlackRock and Fidelity together account for a further 20% of shares, providing a stable institutional base, but with the stock now more than double Corvex's average entry, the activist overhang has a different character than it did eight months ago.
CTAS, the closest liquid peer, added 0.8% on the week, a much steadier profile than VSTS's 2% decline. That relative underperformance, combined with a consensus target sitting below the current price and options traders at their most defensive in weeks, frames the setup heading into the next several months with a next scheduled earnings event on November 27 — the distance to that catalyst is long enough that near-term price action will likely depend on whether management commentary from August 11 reshapes the bull-versus-bear debate around customer retention and margin recovery.
See the live data behind this article on ORTEX.
Open VSTS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
